Latest From IntegenX Inc.
Medical device companies raised $800 million in the fourth quarter of 2011, and venture capital represented half of that amount. Just over $4 billion was spent to acquire medical device companies, down 50% from Q3’s $8 billion. In vitro diagnostics/research financings were well above the previous quarter, raking in a total of $269 million, with late-stage rounds again bringing in most of the Q4 money. Only five M&A deals were completed, totalling $915 million – way down from Q3’s $2.8 billion for the same number of deals.
Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.
Start-Up's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies within the in vitro diagnostics, pharmaceuticals, research/analytical equipment & supplies, and medical device sectors.
- Nanotechnology, Chips, etc.
- Research, Analytical Equipment & Supplies
- Therapeutic Areas
- Microchip Biotechnologies Inc.
- North America
- Parent & Subsidiaries
- IntegenX Inc.
- Senior Management
Stevan Jovanovich, PhD, Pres. & CEO
Ezra Van Gelder, EVP, R&D
Dennis Harris, PhD, CSO
Howard D Goldstein, EVP, Commercial Affairs
- Contact Info
Phone: (925) 701-3400
5720 Stoneridge Dr.
Pleasanton, CA 94588
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.